[1]
KAEWPRADIT, S. et al. 2025. DEVELOPMENT AND STABILITY EVALUATION OF ATORVASTATIN EXTEMPORANEOUS ORAL SUSPENSION FOR ELDERLY PATIENTS. International Journal of Applied Pharmaceutics. 17, 1 (Jan. 2025), 174–180. DOI:https://doi.org/10.22159/ijap.2025v17i1.52519.